[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351212-105":59,"doc-detail-351212-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evidence-for-genotype-specific-optimal-blood-lead-levels-for-cancer-risk-mki67-rs11016073-and-apob-rs1367117","Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk - MKI67 rs11016073 and APOB rs1367117","","This study clarifies how MKI67 rs11016073 and APOB rs1367117 polymorphisms modify the relationship between blood lead (Pb) concentration and cancer risk. Blood Pb was quantified by inductively coupled plasma mass spectrometry, while genotyping used real-time PCR with TaqMan probes. Cancer incidence was tracked over a mean follow-up of 6.2 years in 2,782 women, yielding 210 incident cancers. Associations varied by genotype, revealing genotype-specific optimal Pb ranges and suggesting improved risk stratification through combined MKI67/APOB genotyping for non-linear Pb–cancer patterns.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evidence-for-genotype-specific-optimal-blood-lead-levels-for-cancer-risk-mki67-rs11016073-and-apob-rs1367117/351212/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evidence-for-genotype-specific-optimal-blood-lead-levels-for-cancer-risk-mki67-rs11016073-and-apob-rs1367117/351212.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective?","Question",{"text":112,"@type":113},"To determine how MKI67 rs11016073 and APOB rs1367117 polymorphisms regulate the association between blood lead levels and cancer risk.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were blood lead levels and genotypes measured?",{"text":117,"@type":113},"Blood Pb concentrations were measured using inductively coupled plasma mass spectrometry, and genotyping was performed by real-time PCR with TaqMan probes.",{"name":119,"@type":110,"acceptedAnswer":120},"Do the associations between Pb exposure and cancer risk depend on genetics?",{"text":121,"@type":113},"Yes. The study reports strong genotype-dependent relationships, with genotype-specific optimal Pb ranges, especially for breast cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351212,1790179365,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Article  \nEvidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort  \nKrzysztof Lubi ´nski 1, Wojciech Marciniak 2, Róa Derkacz 2, Adam Kilja ´nczyk 1,2,3, Milena Kilja ´nczyk 1,2, Marcin R. Lener 1, Sandra Pietrzak 1, Cezary Cybulski 1,2, Tadeusz D˛ebniak 1, Tomasz Huzarski 1,2,4, Wojciech Klu´zniak 1,2, Tadeusz Sulikowski 5, Jan Lubi ´nski 1,2, Rodney J. Scott 6,7,8 and Jacek Gronwald 1,2, *  \nAcademic Editor: Christy C. Bridges  \nReceived: 3 January 2026  \nRevised: 23 February 2026  \nAccepted: 27 February 2026  \nPublished: 1 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland; [krzychul123456789@gmail.com](krzychul123456789@gmail.com) (K.L.); [adam.kiljanczyk@pum.edu.pl](adam.kiljanczyk@pum.edu.pl) (A.K.); [milena.matuszczak@pum.edu.pl](milena.matuszczak@pum.edu.pl) (M.K.);  \n[marcinlener@poczta.onet.pl](marcinlener@poczta.onet.pl) (M.R.L.); [sandra.pietrzak@pum.edu.pl](sandra.pietrzak@pum.edu.pl) (S.P.); [cezarycy@pum.edu.pl](cezarycy@pum.edu.pl) (C.C.);  \n[debniak@pum.edu.pl](debniak@pum.edu.pl) (T.D.); [huzarski@pum.edu.pl](huzarski@pum.edu.pl) (T.H.); [wojciech.kluzniak@pum.edu.pl](wojciech.kluzniak@pum.edu.pl) (W.K.);  \n[lubinski@pum.edu.pl](lubinski@pum.edu.pl) (J.L.)  \n2 Read-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Grzepnica, Poland;  \n[wojciech.marciniak@read-gene.com](wojciech.marciniak@read-gene.com) (W.M.); [roza.derkacz@gmail.com](roza.derkacz@gmail.com) (R.D.)  \n3 Department of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical University Hospital No. 1, 70-252 Szczecin, Poland  \n4 Department of Clinical Genetics and Pathology, University of Zielona Góra, ul. Zyty 28, 65-046 Zielona Góra, Poland  \n5 Department of General, Minimally Invasive, and Gastroenterological Surgery, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland; [tadeusz.sulikowski@pum.edu.pl](tadeusz.sulikowski@pum.edu.pl)  \n6 Priority Research Centre for Cancer Research, Innovation and Translation, Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; [rodney.scott@newcastle.edu.au](rodney.scott@newcastle.edu.au)  \n7 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW 2308, Australia  \n8 Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, NSW 2305, Australia  \n* [Correspondence: jgron@pum.edu.pl](Correspondence: jgron@pum.edu.pl)  \nAbstract  \nThis study’s aim was to clarify the regulatory roles of the MKI67 rs11016073 and APOB rs1367117 polymorphisms in the relationship between blood Pb levels and cancer risk. Blood Pb concentrations were measured using inductively coupled plasma mass spectrometry, and genotyping was performed by real-time PCR with TaqMan probes. Cancer incidence was assessed during a mean follow-up of six years and two months. During follow-up, 210 incident cancers were diagnosed among 2782 women. Pb exposure was categorized into quartiles (Q1: \u003C9.44 µg/L; Q2: 9.44–12.58 µg/L; Q3: 12.59–17.16 µg/L; Q4:>17.16 µg µg/L) . The association between Pb levels and cancer risk was strongly genotype dependent. Women carrying APOB non-GG and MKI67 non-AA genotypes exhibited the lowest breast cancer risk at the highest Pb levels (Q4), whereas carriers of APOB GG and MKI67 AA showed the lowest risk at the lowest Pb levels (Q1) . Age-stratified analyses further demonstrated genotype-specific differences in optimal Pb exposure ranges, particularly for breast cancer. Cancer risk associated with Pb exposure is not uniform but depends on genetic background. These findings identify genotype-spec","cbCailJfwow4Z1yq","https://ap.wps.com/l/cbCailJfwow4Z1yq","pdf",522490,17,"English","# Introduction\n## Lead as an environmental contaminant\n## Sources and exposure routes\n## Biological mechanisms of lead carcinogenicity\n## Epidemiological evidence linking blood Pb to cancer risk","[{\"question\":\"What is the study’s main objective?\",\"answer\":\"To determine how MKI67 rs11016073 and APOB rs1367117 polymorphisms regulate the association between blood lead levels and cancer risk.\"},{\"question\":\"How were blood lead levels and genotypes measured?\",\"answer\":\"Blood Pb concentrations were measured using inductively coupled plasma mass spectrometry, and genotyping was performed by real-time PCR with TaqMan probes.\"},{\"question\":\"Do the associations between Pb exposure and cancer risk depend on genetics?\",\"answer\":\"Yes. The study reports strong genotype-dependent relationships, with genotype-specific optimal Pb ranges, especially for breast cancer.\"}]","Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk - MKI67 rs11016073 and APOB rs1367117 | PDF",1790093076,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3045197e3e95f0fd48d195977ef313a8.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d2c22ac906f0ef0227a2d34ae1ffd69.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d3cef1cdafe8165b024eb8991e4987d.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c4c2028ebca1ae4a485157317c95b59.webp",980,1385]